Rabson-Mendenhall syndrome: genes and variants
Explore variant evidence for Rabson-Mendenhall syndrome across 1 analyzed protein (INSR). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Rabson-Mendenhall syndrome
INSR: Insulin receptor
Its activation by insulin coordinates glucose uptake, metabolism, growth, and gene expression through PI3K-AKT and MAPK pathways. Biallelic severe loss-of-function variants cause Donohue or Rabson-Mendenhall syndromes, while heterozygous variants can cause severe insulin resistance.
8 ClinVar pathogenic / likely pathogenic and 41 uncertain variants in INSR have source records linked to Rabson-Mendenhall syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Rabson-Mendenhall syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| INSR R1020Q | 1020 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| INSR R145C | 145 | Extracellular | Pathogenic / likely pathogenic (★) |
| INSR R1119Q | 1119 | Protein kinase | Pathogenic / likely pathogenic (★) |
| INSR G132S | 132 | Extracellular | Pathogenic / likely pathogenic |
| INSR R256C | 256 | Extracellular | Pathogenic / likely pathogenic |
| INSR N42K | 42 | Extracellular | Pathogenic / likely pathogenic |
| INSR S835I | 835 | Fibronectin type-III 2 | Pathogenic / likely pathogenic |
| INSR A842V | 842 | Fibronectin type-III 2 | Pathogenic / likely pathogenic |
Which prediction tools work for Rabson-Mendenhall syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 95 out of 100
- VARITY: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 93 out of 100
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 90 out of 100
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 87 out of 100
- SIFT: 87 out of 100
- MetaSVM: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 83 out of 100
- MetaLR: 79 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phastCons: 70 out of 100
Same protein, different disease
- Leprechaunism syndrome also has ClinVar records linked to INSR variants; they fall mostly in different places as the Rabson-Mendenhall syndrome variants (14 pathogenic / likely pathogenic).
- Insulin-resistant diabetes mellitus AND acanthosis nigricans also has ClinVar records linked to INSR variants; they fall mostly in different places as the Rabson-Mendenhall syndrome variants (7 pathogenic / likely pathogenic).
Diseases related to Rabson-Mendenhall syndrome
- Monogenic diabetes, also linked to INSR
- Type 2 diabetes mellitus, also linked to INSR
- Diabetes mellitus, also linked to INSR
- Leprechaunism syndrome, also linked to INSR
- Type 1 diabetes mellitus, also linked to INSR
- Insulin-resistant diabetes mellitus AND acanthosis nigricans, also linked to INSR
- Hyperinsulinism due to INSR deficiency, also linked to INSR
Frequently asked questions
Which genes have records linked to Rabson-Mendenhall syndrome?
This view contains 1 analyzed proteins: INSR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 55 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center